Cited by 47Estrogen and related hormone effectsPregnancy-related medical researchPreterm Birth and Chorioamnionitis

Metabolites of progesterone and the pregnane X receptor: a novel pathway regulating uterine contractility in pregnancy?

Mitchell, Bryan F., Mitchell, Jana M., Chowdhury, Jeeshan, Tougas, Michelle, Engelen, Sanne M.E., Senff, Nancy, Heijnen, Iris, Moore, John T. +3 more·2005·American Journal of Obstetrics and Gynecology

Abstract

Objective The purpose of this study was to determine the role of 5beta-dihydroprogesterone (5beta-DHP), acting through the nuclear receptor pregnane X receptor (PXR), in regulating uterine contractility.Study design Uterine contractility was studied in tissues from women, rats, and mice. Messenger RNA was assessed using reverse transcriptase-polymerase chain reaction (RT-PCR), and protein was measured using enzyme assays, immunofluorescence microscopy, and Western analyses.Results Human and rat uterine tissues contain mRNA and protein for 5beta-reductase and for PXR. Acute in vitro treatment with 5beta-DHP causes rapid uterine relaxation that is not mediated by PXR. Chronic in vivo administration of 5beta-DHP to mice with intact PXR, but not in mice with disrupted PXR, causes an increased effect of 1400W, a specific inhibitor of inducible nitric oxide synthase (iNOS). This suggests that 5beta-DHP increased iNOS-modulated uterine tone, as occurs during pregnancy.Conclusion These data support the hypothesis that metabolites of progesterone may act chronically through a PXR-mediated mechanism to regulate uterine contractility.

Integrity signals

Registry

Crossref · 10.1016/j.ajog.2005.01.040

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In liver and some peripheral tissues such as placenta and myometrium, AKR1D1 reduces progesterone to 5β-DHP, while SRD5A1 and SRD5A2 form 5α-DHP.

    “In liver and some peripheral tissues (e.g. placenta and myometrium) AKR1D1 catalyzes reduction of progesterone to 5β-dihydroprogesterone (5β-DHP) while the 5α-reductases SRD5A1 and SRD5A2 form 5α-dihydroprogesterone (5α-DHP)”
  • Higher AKR1C1 and AKR1C2 levels in endometriotic tissue may contribute to increased conversion of progesterone to 20α-hydroxy-pregn-4-ene-3-one.

    “Higher levels of AKR1C1 and AKR1C2 in endometriotic tissue may contribute to enhanced metabolism of the protective progesterone to 20α-hydroxy-pregn-4-ene-3-one”
  • Concurrent action of SRD5A1 may lead to formation of pro-proliferative 5α-pregnanes.

    “and the concurrent action of SRD5A1 may lead to the formation of the pro-proliferative 5α-pregnanes [39] (N. Beranič and T. Lanišnik Rižner, unpublished data).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mitchell, B. F., Mitchell, J. M., Chowdhury, J., Tougas, M., Engelen, S. M. E., Senff, N., Heijnen, I., Moore, J. T., Goodwin, B., Wong, S., & Davidge, S. T.
Affiliations
  • University of Alberta (CA)
  • GlaxoSmithKline (United States) (US)
Corresponding author
Mitchell, Bryan F.
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
2005-04
Volume
192
Issue
4
Pages
1304-1313
ISSN
0002-9378 (ISSN-L)
OpenAlex
W1992013033
Cited by
47
References
36
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 1 · 2014: 3 · 2013: 2 · 2012: 4
FWCI
2.33
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Funders
University of Alberta
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy-related medical research
  • Health Sciences › Medicine › Epidemiology › Preterm Birth and Chorioamnionitis
Keywords
pregnane X receptor, progesterone metabolites, uterine contractility, 5beta-reductase, inducible nitric oxide synthase, 1400W, uterine relaxation, pregnancy, uterine tone
MeSH terms
Pregnane X Receptor, Analysis of Variance, Animals, Base Sequence, Enzyme-Linked Immunosorbent Assay, Female, Humans, Microscopy, Fluorescence, Molecular Sequence Data, Myometrium, Organ Culture Techniques, Pregnancy, Pregnancy, Animal, Probability, Progesterone, Receptors, Steroid, RNA, Messenger, Species Specificity, Uterine Contraction, Blotting, Western, Up-Regulation, Rats, Sprague-Dawley, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Models, Animal, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review